UK Challenges

We have a number of UK based challenges, from trekking to sailing, so why not take a look at what we have to offer and take the challenge today.

Running
Cycling
Overseas
Skydiving
UK Challenges
Virtual Events

1 January 2024 - 31 December 2025

Tell us about another event

Taking on an event for Leukaemia Care and its not listed here? Tell us about it

1 January 2024 - 31 December 2025

Zipwire

Take on the thrilling experience of flying at 100 miles per hour - all while raising money for us to support blood cancer patients

1 January 2024 - 31 December 2025

IronMan Triathlon

Push yourself to the limit by taking part in an Ironman race as part of #TeamLC!

1 January 2024 - 31 December 2025

Bungee jump

Take the plunge for Leukaemia Care at various venues across the UK

1 January 2024 - 31 December 2025

Ultra Challenges

Feeling up for a challenge? Take on one of our fantastic Ultra Challenges in support of those living with leukaemia!

1 January 2025 - 31 December 2025

Adrenaline Challenges

Feel the thrill whilst fundraising for those living with Leukaemia by taking on one of our adrenaline challenges!

10 May 2025 - 21 September 2025

Tough Mudder Events 2025

The ultimate obstacle course challenge now has multiple obstacles over a 5 to 15 Kilometre run. Take on the challenge at a local of your choice in 2025,

26 April 2026

2026 TCS London Marathon

Register your interest in our Leukaemia Care 2026 TCS London Marathon places today and play a vital part in securing support for anyone whose life has been impacted by a blood cancer, like leukaemia.

Myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) are diseases of the bone marrow. MDS is characterised by abnormal, immature blood cells that do not work properly. MDS is a type of cancer, but it is sometimes also called ‘bone marrow failure’. Here, we cover what MDS is, how it’s diagnosed, and what treatment you might have.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

November 11th

Additional treatment for AML patients now available in Scotland

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today. ...

October 31st

Leukaemia Care’s response to the 2024 Autumn Budget

"We welcome the increase in the NHS budget. However..." - Colin Dyer, Chief Executive at Leukaemia Care shares the charity's response....

October 22nd

NEW NHS treatment option for myelofibrosis patients

Certain patients with myelofibrosis will have access to fedratinib to treat myelofibrosis, thanks to a decision made by the National Institute for Health and Care Excellence (NICE). ...